The present invention relates to binding molecules, in particular antibodies and immunoglobulins to human CCL21 (hCCL21) and their use in the treatment and/or prevention of human diseases and disorders, particularly those of a fibrotic nature. Pharmaceutical compositions, methods of manufacture and methods of treatment are also disclosed.
申请公布号
WO2011080050(A2)
申请公布日期
2011.07.07
申请号
WO2010EP69430
申请日期
2010.12.10
申请人
NOVARTIS AG;BARDROFF, MICHAEL;EWERT, STEFAN;JAEGER, UTE;JARAI, GABOR;KUNZ, CHRISTIAN CARSTEN SILVESTER;WIESEHAN, KATJA
发明人
BARDROFF, MICHAEL;EWERT, STEFAN;JAEGER, UTE;JARAI, GABOR;KUNZ, CHRISTIAN CARSTEN SILVESTER;WIESEHAN, KATJA
